首页 › 基金 › Vivo Capital, LLC › KTTA
Vivo Capital, LLC 对 KTTA 的持仓历史
Pasithea Therapeutics Corp · 医疗保健
Vivo Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 KTTA(Pasithea Therapeutics Corp)372,796 股,市值约 US$184K,约占其申报组合的 0.02%,在其申报持仓中市值排名第 47 位。 Vivo Capital, LLC 最近 4 个申报季度中有 4 个季度披露了 KTTA 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Vivo Capital, LLC 对 KTTA 的持仓演变
Vivo Capital, LLC 于 Q4 2025 首次披露 KTTA 持仓:2,100,000 股(约 US$2.7M)。 在 4 次申报中,Vivo Capital, LLC 0 次增持、2 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 372,796 股、市值约 US$184K,环比减持 -92,675 股。。 持仓曾出现大幅变动:Q2 2026 减持约 78% (随后一个季度股价下跌 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 2.10M | $2.71M | 新进 |
| Q1 2026 | 2.10M | $1.56M | 持有 |
| Q2 2026 | 465.47K | $239.90K | 减持 |
| Q3 2026 | 372.80K | $183.79K | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KTTA 与 13F 数据
KTTA(Pasithea Therapeutics Corp)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 KTTA,申报仓位最大的包括:Stonepine Capital Management, LLC (US$1.1M), Squadron Capital Management LLC (US$515K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KTTA 的基金
- Stonepine Capital Management, LLC 2.20M 股 · $1.13M · Q2 2026
- Squadron Capital Management LLC 1.00M 股 · $515.40K · Q2 2026
更多关于 Vivo Capital, LLC
常见问题
How long has Vivo Capital, LLC held KTTA?
Vivo Capital, LLC has disclosed KTTA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Vivo Capital, LLC's current position in KTTA?
As of Q3 2026, Vivo Capital, LLC holds 372.80K shares of KTTA (Pasithea Therapeutics Corp), valued at $183.79K, representing 0.02% of its reported portfolio and ranking #47.
Has Vivo Capital, LLC been buying or selling KTTA?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC reduced its position in KTTA.
Which other funds hold KTTA?
Other major institutional holders of KTTA include Stonepine Capital Management, LLC, Squadron Capital Management LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.